Assort Health raises $120M Series C to scale patient journey platform →
Fierce Healthcare's Heather Landi covers Assort Health's $120M Series C led by Menlo Ventures, reaching unicorn status to scale its voice AI agent platform.
Pulse 2.0's Amit Chowdhry details Assort Health's $120M Series C to scale AI agents across scheduling, intake, and referrals for provider groups.
Modern Healthcare's Joyce Famakinwa covers Assort Health's $120M Series C, led by Menlo Ventures at a $1.2B valuation, to scale AI agents for patient access.
Newcomer's recap of the Cerebral Valley Voice Summit features Assort Health co-founder Jeffery Liu citing 150M patient interactions across 5,000 providers.
Digital Health Wire spotlights the launch of Assort Activate, calling out early traction across early deployments, including a 64% referral scheduling conversion rate at SENTA Partners as proof that proactive AI outreach is moving from pilot to scale in provider operations.
Assort Health is named to CB Insights' 2026 AI 100, the annual list of the 100 most innovative artificial intelligence startups, recognizing the company's traction in applying agentic AI to one of healthcare's most painful workflows: patient access.
Fierce Healthcare details the launch of Assort Activate, Assort Health's new outbound AI agent that proactively reaches patients to fill care gaps, reschedule appointments around disruptions, and accelerate referrals, already deployed across 1,000+ providers.
Built on Assort’s industry-leading voice AI platform and already in use across 1,000+ providers, Activate proactively engages patients across channels to grow booked appointments, accelerate payments, and close care gaps at scale
Futurist features Assort CEO Jon Wang in the VIVE 2026 Healthcare Innovation Report, exploring how AI-native patient access is reshaping the front door of care.
TIME explores the patient access crisis and highlights how Assort customer Dr. Titus Abraham is using AI-powered phone triage to manage call surges and free up staff for complex care.
Hundreds of Dermatology Providers Partner with Assort Health to Scale Patient Access Across Complex, High-Volume Care Workflows
At Annapolis Internal Medicine, patient satisfaction ratings jumped, labor capacity more than doubled without adding staff, and hold times dropped from four minutes to under one minute, all because of the agentic AI technology.
Assort Health is using AI agents (voice, text, email, web) to make it easier for patients to interface with providers. Their goal is to use agentic AI to give practices the ability to handle most interactions with patients, with the hardest workflow typically being scheduling appointments.
Anyone who’s tried to schedule a doctor’s appointment is painfully familiar with the sound of healthcare inefficiency: hold music. The painful experience of listening to Opus No. 1 after giving the office your personal information, only to get transferred…
San Francisco – October 23, 2025 – Assort Health, the most comprehensive patient experience platform powered by specialty-specific agentic AI, proudly announces its recognition on the Redpoint AI64. This prestigious list highlights the 64 up-and-coming enterprise AI applications.
Assort health landed $76 million in Series B funding to scale its AI-powered patient access platform. The company deploys AI voice agents to automate clinical call center operations, handling appointment scheduling, insurance verification, and patient inquiries.
Assort Health, an agentic artificial intelligence company focused on patient scheduling, received $76 million in a Series B funding round. The round was led by venture capital firm Lightspeed Venture Partners. Other investors included Felicis, First Round Capital, Chemistry, A* Capital, Liquid2 and Quiet Capital.
Assort Health, the most comprehensive patient experience platform powered by specialty-specific agentic AI, today announced the close of a $76 million Series B financing round led by Lighspeed Venture Partners, with investments by Felicis, First Round Capital, Chemistry, A*, Liquid2, and Quiet Capital.
Assort Health recognized for achievements in patient communication and engagement
Assort Health and Confido Health both announced double-digit rounds this week for voice AI tools.
Voice AI startup Assort Health has raised a $76 million series B round, bringing its total funding to $102 million in just the last four months.
Assort's $76-million financing was led by Lightspeed Venture Partners, with Felicis, First Round Capital, Chemistry, A*, Liquid2 and Quiet Capital also joining. Coming just four months after a series A, the round brings its total to %102 million.
Assort Health, which offers an agentic AI patient experience platform, announced it has closed a $76 million Series B funding round led by Lightspeed Venture Partners, bringing its total raise to $102 million.
Assort Health, a San Francisco, CA-based provider of a patient experience platform empowered by specialty-specific agentic AI, raised $76M in Series B funding.
Lightspeed is thrilled to announce their investment in Assort Health, the agentic AI platform that is quickly becoming a go-to choice for provider organizations looking to reimagine patient access.
On September 30, 2025, Assort Health, a comprehensive patient experience platform powered by specialty-specific agentic AI, announced the close of a $76 million Series B financing round led by Lightspeed Venture Partners, with investments by Felicis, First Round Capital, Chemistry, A*, Liquid2, and Quiet. A Wilson Sonsini Goodrich & Rosati team led by Lang Liu, Alex Youssef, and Andrew Lu advised Assort Health on the transaction.
On Sept. 30, San Francisco-based Assort Health, which says it has created a patient experience platform powered by specialty-specific agentic AI, closed a $76 million Series B financing round. In another example, Duke Health said it would co-develop and test agentic AI products with Trase Systems, with the first phase of development beginning at the Duke Heart Center.
Assort Health, a patient communications automation startup, raised $76m in Series B funding. Lightspeed led, joined by First Round, Chemistry, Felicis, A*, Liquid 2 Ventures, and Quiet Capital.
Assort Health, a startup founded in 2023 by Jeff Liu and Jon Wang, raised $76 million in a Series B round led by Lightspeed to advance its voice AI platform for healthcare. The platform, which has handled 42 million patient interactions, automates scheduling and administrative tasks, allowing providers to focus on care.
Series B, led by Lightspeed Venture Partners, will turbocharge company’s rapid growth and extend their lead role in using AI to transform the patient experience
Assort Health’s Assort Ascend summit, scheduled for September 19-21, 2025, in Napa Valley, will unite healthcare and tech leaders to advance AI-driven patient engagement and provider operations, using its platform to eliminate wait times and improve care access.
Assort Health’s Assort Ascend summit, set for September 19-21, 2025, in Napa Valley, will unite healthcare and tech leaders to advance AI-driven patient engagement and operational efficiency, leveraging its platform to eliminate wait times and improve care access.
Assort Health’s Assort Ascend summit, set for September 19-21, 2025, in Napa Valley, will gather healthcare leaders to explore AI-driven solutions for patient engagement and provider operations, addressing challenges like increased wait times with its generative AI platform that eliminates long hold times.
Forbes Cloud 100 Rising Stars 2025 highlights Assort Health, a San Francisco healthcare startup using generative AI to manage 22 million+ patient calls, cutting hold times from 11 to 1 minute.
We are grateful to share that Assort Health was named to Forbes’ Next Billion-Dollar Startups 2025 list.
First Round highlights how Assort’s Voice AI agent is setting the standard for accuracy and trust in healthcare automation. The piece underscores our unprecedented achievement, solving over 900,000 real-world edge cases in patient scheduling and communication. This rigor was built by working specialty-by-specialty, practice-by-practice, to create an AI system that can handle the complexity of healthcare workflows with near-flawless precision. Our approach transforms technical challenges into powerful competitive moats, fueled by proprietary data and relentless governance.
Assort Health, a developer of voice AI for handling patient calls, raised $26 million co-led by First Round Capital and Chemistry.
.svg)
Funding news of note: Assort Health secures $26M to expand specialty-specific generative AI platform for managing patient phone calls
Voice AI startup Assort Health secured $26M of growth funding to replace healthcare’s notoriously brutal phone trees and hold times with intelligent triage and scheduling.
We’ve all been there. Your symptoms flare up again and you call your doctor, hoping for a quick referral to a specialist. After several minutes of hold music, someone finally picks up — only to put you on hold again while they check your information. You get an appointment, but later discover you didn’t have the right authorization from your insurance provider or were sent to the wrong specialist — a frustratingly common scenario.
Assort Health, the most advanced specialty-specific AI platform for managing patient phone calls, announced a new round of institutional financing co-led by First Round Capital and Chemistry, with participation from existing investor Quiet Capita
Assort Health, an AI platform for specialty-specific patient call management, secured $26 million in a funding round co-led by First Round Capital and Chemistry, with Quiet Capital and existing investors like Four Acres, Tau Ventures, and prominent angel investors from Athena Health, Flatiron Health, and others.
Assort Health, a leading AI platform for managing specialty-specific patient phone calls, announced the successful completion of a $22 million Series A funding round. The round was co-led by First Round Capital and Chemistry, with additional support from existing partner Quiet Capital.
Assort Health, a company specializing in AI solutions for managing patient phone calls in healthcare, has announced a new round of institutional financing co-led by First Round Capital and Chemistry, with continued support from existing investor Quiet Capital, bringing the company’s total funding to $26M.
Jon Wang and Jeff Liu met dozens of prospective cofounders—until they met each other. Wang had left medical school years earlier to pursue a startup career, while Liu was a former Facebook engineer. They were looking to begin their lives anew as founders of their own startup, and lived more than 2,500 miles apart, with Liu in San Francisco and Wang in New York.
Assort Health, a startup building voice AI agents for healthcare, has raised its $22 million Series A led by First Round and Chemistry.
Assort Health Secures $26 Million in Funding to Expand Specialty-Specific Generative AI Platform for Managing Patient Phone Calls
CMS Launches a new payment model, MA Final Rate notice watch, Modern Health Shutdown, and more
